Email Alert RSS
Volume 11 Issue 6
Nov.  2020
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2020  >  11(6): 698-702
LIU Jie, LUO Yi-xin, LIU Zhao-rui, LIU Yue-hua, ZHANG Wei, LU Zhao-hui. WHO-EORTC Classification of Primary Cutaneous Lymphomas:Updates and Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 698-702. doi: 10.3969/j.issn.1674-9081.2020.06.011
Citation: LIU Jie, LUO Yi-xin, LIU Zhao-rui, LIU Yue-hua, ZHANG Wei, LU Zhao-hui. WHO-EORTC Classification of Primary Cutaneous Lymphomas:Updates and Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 698-702. doi: 10.3969/j.issn.1674-9081.2020.06.011
shu

WHO-EORTC Classification of Primary Cutaneous Lymphomas:Updates and Interpretation

doi: 10.3969/j.issn.1674-9081.2020.06.011
  • 1.

    Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Dermatology, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands

  • 3.

    Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 4.

    Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds:

The National Key Research and Development Program of China 2016YFC0901500

Beijing Natural Science Foundation 7182127

More Information
  • Corresponding author: LIU Jie  Tel: 86-10-69151536, E-mail: Liujie04672@pumch.cn
  • Received Date: 2020-04-23
  • Accepted Date: 2020-06-02
    • Available Online: 2020-06-02
  • Publish Date: 2020-11-30
    Abstract
  • Primary cutaneous lymphomas (PCL) are a group of non-Hodgkin's lymphomas that are presented with specific clinical manifestations and histopathological characteristics. The classification of PCL published by World Health Organization-European Organization for Research and Treatment of Cancer (WHO-EORTC) in 2005 was the important diagnostic criteria and classification basis for cutaneous lymphomas. With research progression, WHO-EORTC updated the classification of PCL in 2018, adding three subtypes of PCL, namely, chronic active Epstein Barr virus (EBV) infection, primary cutaneous acral CD8+ T-cell lymphoma, and EBV-positive mucocutaneous ulcer. Besides, some subtypes of PCL were revised, including lymphomatoid papulosis, primary cutaneous marginal zone lymphoma, and primary cutaneous CD4+ small/medium T cell lymphoproliferative disease. This article interprets the update of WHO-EORTC classification of PCL.
    • FullText(HTML)
  • loading
    • References(23)
  • [1] Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas[J]. Blood, 2005, 105: 3768-3785. doi:  10.1182/blood-2004-09-3502
    [2] Elder DE, Massi D, Scolyer RA, et al. WHO Classification of Skin Tumours[M]. 4th ed. France: IARC Press, 2018.
    [3] Tokura Y, Ishihara S, Tagawa S, et al. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma[J]. J Am Acad Dermatol, 2001, 45: 569-578. doi:  10.1067/mjd.2001.114751
    [4] Rodriguez-Pinilla SM, Barrionuevo C, Garcia J, et al. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults[J]. Am J Surg Pathol, 2010, 34: 1773-1782. doi:  10.1097/PAS.0b013e3181fbb4fd
    [5] Cho KH, Lee SH, Kim CW, et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases[J]. Br J Dermatol, 2004, 151: 372-380. doi:  10.1111/j.1365-2133.2004.06038.x
    [6] 王诗琪, 池诚, 刘洁.皮肤T细胞淋巴瘤局部用药和物理治疗的研究进展[J].协和医学杂志, 2019, 10: 157-161. doi:  10.3969/j.issn.1674-9081.2019.02.014

    Wang SQ, Chi C, Liu J. Advance in the Topical Medication and Physical Therapy for Cutaneous T Cell Lymphoma[J]. Xie He Yi Xue Za Zhi, 2019, 10: 157-161. doi:  10.3969/j.issn.1674-9081.2019.02.014
    [7] Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases[J]. Blood, 2012, 119: 673-686. doi:  10.1182/blood-2011-10-381921
    [8] Miyake T, Yamamoto T, Hirai Y, et al. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites[J]. Br J Dermatol, 2015, 172: 56-63. doi:  10.1111/bjd.13411
    [9] Tokura Y, Ishihara S, Tagawa S, et al. Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma[J]. J Am Acad Dermatol, 2001, 45: 569-578. doi:  10.1067/mjd.2001.114751
    [10] Petrella T, Maubec E, Cornillet-Lefebvre P, et al. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?[J]. Am J Surg Pathol, 2007, 31: 1887-1892. doi:  10.1097/PAS.0b013e318068b527
    [11] Perry AM, Warnke RA, Hu Q, et al. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract[J]. Blood, 2013, 122: 3599-3606. doi:  10.1182/blood-2013-07-512830
    [12] Tabanelli V, Valli R, Righi S, et al. A unique case of an indolent myometrial T-cell lymphoproliferative disorder with phenotypic features resembling uterine CD8+ resident memory T cells[J]. Pathobiology, 2014, 81: 176-182. doi:  10.1159/000363346
    [13] Alberti-Violetti S, Fanoni D, Provasi M, et al. Primary cutaneous acral CD8 positive T-cell lymphoma with extra-cutaneous involvement: A long-standing case with an unexpected progression[J]. J Cutan Pathol, 2017, 44: 964-968. doi:  10.1111/cup.13020
    [14] Dojcinov SD, Venkataraman G, Pittaluga S, et al. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma[J]. Blood, 2011, 117: 4726-4735. doi:  10.1182/blood-2010-12-323238
    [15] Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression[J]. Am J Surg Pathol, 2010, 34: 405-417. doi:  10.1097/PAS.0b013e3181cf8622
    [16] Kumar S, Fend F, Quintanilla-Martinez L, et al. Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression[J]. Am J Surg Pathol, 2000, 24: 66-73. doi:  10.1097/00000478-200001000-00008
    [17] Natkunam Y, Goodlad JR, Chadburn A, et al. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1[J]. Am J Clin Pathol, 2017, 147: 129-152. doi:  10.1093/ajcp/aqw214
    [18] Saggini A, Gulia A, Argenyi Z, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases[J]. Am J Surg Pathol, 2010, 34: 1168-1175. doi:  10.1097/PAS.0b013e3181e75356
    [19] Kempf W, Kazakov DV, Schärer L, et al. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas[J]. Am J Surg Pathol, 2013, 37: 1-13. doi:  10.1097/PAS.0b013e3182648596
    [20] Karai LJ, Kadin ME, Hsi ED, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis[J]. Am J Surg Pathol, 2013, 37: 1173-1181. doi:  10.1097/PAS.0b013e318282d01e
    [21] van Maldegem F, van Dijk R, Wormhoudt TA, et al. The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment[J]. Blood, 2008, 112: 3355-3361. http://europepmc.org/abstract/MED/18687986
    [22] Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets[J]. Am J Surg Pathol, 2010, 34: 1830-1841. doi:  10.1097/PAS.0b013e3181f72835
    [23] Swerdlow SH. Cutaneous marginal zone lymphomas[J]. Semin Diagn Pathol, 2017, 34: 76-84. doi:  10.1053/j.semdp.2016.11.007
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (424) PDF downloads(49) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return